Why Is All The GLP-1 Data So Confusing?
- May 15
- 2 min read
The GLP-1 data is everywhere. And somehow, nobody knows anything. Leaders across industries – restaurants, retail, beauty, even fitness and insurance planning – want to know one thing:
How are GLP-1s impacting me today, and how will they affect me in the future?
I can tell you this: tomorrow’s GLP-1 users are going to look different than today’s.
I've read over 30 GLP-1 studies. Every single one told me something different. No wonder I hear from leaders across industries, "It's so confusing. The data is all over the place.”
Even just the basic demographics of who is using GLP-1s varies massively depending on who sponsored the survey!
And – the public data… it is fairly surface level.
Three barriers are crashing down simultaneously...
1) Needles - now pills are becoming widely available
2) Accessibility - it was expensive, now costs are coming down and insurance is picking up the bill
3) Openness - obesity as a disease, people are openly sharing more about their GLP-1 usage
I want to cut through the noise.
I’ve got data that maps the current & next phase of impact like you’ve never seen:
25 business verticals
60 restaurant brands
20 retail brands
Is yours one of them?
On June 15th. A more complete picture. Finally.
Pre-orders start next Friday - May 22nd!
Lisa W. Miller is a consumer insights researcher, strategist, and founder of LWM Associates. A former VP of Innovation at Brinker International and VP of Insights & Strategy at Frito-Lay/PepsiCo, she has conducted proprietary research on Gen Z, American consumer behavior, and workplace dynamics. Her data has been featured in the Wall Street Journal and across more than 300 media appearances. Her podcast and newsletter, The Business of Joy, explores how leaders and consumers navigate an uncertain world.
Comments